Unlocking Immunity Within: Inflammatory Monocytes Stimulate T Cells at Immune Hubs in the Tumor Microenvironment
- 15 July 2025
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 145 (9) , 2131-2134
Abstract
No abstract availableKeywords
Funding Information
- European Research Council (101125797)
- European Research Council (759590)
- Horizon 2020 Framework Programme (955951)
- Boehringer Ingelheim
- Österreichische Forschungsförderungsgesellschaft
- Vienna Science and Technology Fund
This publication has 10 references indexed in Scilit:
- DREAMseq: A phase III trial of treatment sequences in BRAFV600-mutant (m) metastatic melanoma (MM)—Final clinical results.Journal of Clinical Oncology, 2025
- Cancer cells impair monocyte-mediated T cell stimulation to evade immunityNature, 2024
- Human lung cancer harbors spatially organized stem-immunity hubs associated with response to immunotherapyNature Immunology, 2024
- The cancer-immunity cycle: Indication, genotype, and immunotypeImmunity, 2023
- Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated BRAF-Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II TrialJournal of Clinical Oncology, 2023
- Spatiotemporal co-dependency between macrophages and exhausted CD8+ T cells in cancerCancer Cell, 2022
- Anti-PD-1/L1 lead-in before MAPK inhibitor combination maximizes antitumor immunity and efficacyCancer Cell, 2021
- CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironmentCell, 2021
- Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanomaNature Cancer, 2021
- Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalkNature, 2014